Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.

The Prostate - 1 Sept 2021

Wei Jun, Yang Wancai, Shi Zhuqing, Lu Lucy, Wang Qiang, Resurreccion W Kyle, Engelmann Valentina, Zheng S Lilly, Hulick Peter J, Cooney Kathleen A, Isaacs William B, Helfand Brian T, Lu Jim, Xu Jianfeng

Abstract excerpt

BACKGROUND: Germline testing for prostate cancer (PCa) is now recommended by the National Comprehensive Cancer Network. While multi-gene testing has been proposed, evidence for their association with PCa risk is not well established. METHODS: We tested associations of pathogenic/likely pathogenic mutations in 10 guideline-recommended genes (ATM, BRCA1, BRCA2, CHEK2, PALB2, MLH1, MSH2, MSH6, PMS2, and HOXB13) with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Prostatic Neoplasms

Share to Risk Assessment

Source

Identifiers

PMID: 34254341
DOI: 10.1002/pros.24195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.PMID 34254341Read ↗

Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN Guidelines.Semantic proximity Read ↗

Recent Insights on Genetic Testing in Primary Prostate Cancer.Semantic proximity Read ↗

Hereditary Prostate Cancer: Genes Related, Target Therapy and PreventionSemantic proximity Read ↗

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.Semantic proximity Read ↗

Prostate Cancer Germline Variations and Implications for Screening and Treatment.Semantic proximity Read ↗

Hereditary prostate cancer - Primetime for genetic testing?Semantic proximity Read ↗

Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.Semantic proximity Read ↗

Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis.Semantic proximity Read ↗

Germline genetics of prostate cancer.Semantic proximity Read ↗

Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?Semantic proximity Read ↗

Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 ControlsSemantic proximity Read ↗

Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.